TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Roche Pharmaceuticals A/S
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
826,964
|
761,417
|
1,571,168 |
| Earnings before taxes |
31,565
|
43,846
|
35,780 |
| Total assets |
355,290
|
357,642
|
779,352 |
| Current assets |
342,285
|
341,909
|
375,525 |
| Current liabilities |
186,154
|
216,480
|
217,807 |
| Equity capital |
163,860
|
139,583
|
489,141 |
| - share capital |
4,000
|
4,000
|
4,000 |
| Employees (average) |
150
|
150
|
150 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
46.1%
|
39.0%
|
62.8% |
| Turnover per employee |
5,513
|
5,076
|
10,474 |
| Profit as a percentage of turnover |
3.8%
|
5.8%
|
2.3% |
| Return on assets (ROA) | |||
| Current ratio |
183.9%
|
157.9%
|
172.4% |
| Return on equity (ROE) |
19.3%
|
31.4%
|
7.3% |
| Change turnover |
65,547
|
-809,751
|
838,336 |
| Change turnover % |
9%
|
-52%
|
114% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.